Infinity Pharmaceuticals, Inc. (INFI) Tops Q1 EPS by 6c

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.78), $0.06 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Stifel Positive on Viking Holdings (VIK) Earnings: '2027 Booking Curves Continue To Show Strength'
• UBS Reiterates Buy Rating on Gap, Inc. (GAP), Says Earnings Could Be a High-Volatility Event